Skip to main content
. 2017 Dec 22;9(12):10754–10764. doi: 10.18632/oncotarget.23610

Table 2. Clinicopathological data on patients diagnosed with gastric cardia NEC.

NO. Gender Age Tumor size Gross type Symptom Histopathology (NECs with) Stage IHC-positive staining Treatment (Surgery) Follow-up
1 M 68 2 cm ulcerating GR AD T2N0M0 (I) Syn, CK NA
2 M 69 4.5 cm fungal VB AD T3N0M0 (II) Syn, CgA, CEA NA
3 M 65 0.5 cm fungal VB AD T3N0M0 (II) Syn, CgA CT NA
4 M 63 2.3 cm ulcerating GR MAD T4N3M0 (III) Syn, CK8/18 5
5 M 58 1.7 cm ulcerating VB AD T4N2M0 (III) Syn, CgA 10
6 M 78 0.8 cm ulcerating GR Pure T3N1M0 (II) Syn, CD56 CT NA
7 M 44 1.1 cm ulcerating GR Pure T3N0M0 (II) Syn, CD56 NA
8 M 65 3.5 cm ulcerating VB AD T4N0M0 (III) Syn, CK8/18 NA
9 M 65 1.3 cm ulcerating GR Pure T3N1M0 (II) Syn, CgA, CK 18
10 M 78 0.5 cm fungal GR Pure T4N0M0 (III) Syn, CgA, CK CT NA
11 F 69 0.9 cm fungal GR MAD T3N1M0 (II) Syn, CgA NA
12 F 63 3.4 cm ulcerating VB Pure T4N0M0 (III) Syn, CD56 CT 10
13 F 29 2.2 cm ulcerating GR AD T2N0M0 (I) Syn, CK CT+RT Alive

M: male; F: female; GR: gastroesophageal reflux, VB: vomit or blood in the stool CT: chemotherapy; RT: radiotherapy